MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.48
-0.03 (-6.02%)
As of Jul 4, 10:40 PM ET ·
Financial Highlights (FY 2026)
Revenue
110.90M
Net Income
-34,460,458
Gross Margin
64.5%
Profit Margin
-31.1%
Rev Growth
+42.8%
D/E Ratio
4.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 110.90M 77.67M 27.35M 20.96M
Gross Profit 71.59M 50.13M 9.30M 7.12M
Operating Income -14,971,653 -9,436,576 6.75M 5.11M
Net Income -34,460,458 -21,720,297 6.20M 4.50M
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Rev Growth +42.8% +42.8% -0.5% +20.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.79M 9.79M 71.52M 80.61M
Total Equity 2.45M 2.45M 72.48M 68.20M
D/E Ratio 4.00 4.00 0.99 1.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,364,064 -4,234,092 9.44M 6.87M
Free Cash Flow 4.10M 4.11M